~~<i id='33026DCD2A'><strike id='33026DCD2A'><tt id='33026DCD2A'><pre id='33026DCD2A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

leisure time

author：entertainment 2025-09-29 23:03:45 - browse：868

Introducing STAT’s Biotech Q2 Scorecard, our emoji-enabled means of tracking 12 make-or-break events expected over the next three months.

When each clinical trial or FDA decision crosses the wires, we’ll add in the appropriate rocket ship, grimace face, bulging bicep or broken heart — whatever captures the mood.

Read on for brief explanations of what we’re watching for from each company.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： 'Brian's Song' at 50 still offers lessons about cancer for today

leisure time

focus

leisure time

focus

knowledge

SusanUlan,right,greetshergranddaughterIvy,andherdaughterJessieAnderson,atAnderson'shome.SuzanneKreit

WSS

Drug for rare kidney disease narrowly misses mark in clinical trial

Many breast cancer patients receive more radiation than needed

Doctors are clamoring for more clarity on Paxlovid prescribing

Emergency workers more likely to restrain Black patients: study

Emergency workers more likely to restrain Black patients: study

Sweden knocks USA out of World Cup in penalty kicks

explore

leisure time

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

CDC advisers recommend seasonal use of Pfizer RSV shot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Changes to biosimilar regulatory framework must prioritize patients

Heart attack and stroke risk calculators need revising

Feed a cold, starve a fever? Here’s what science says

Sports medicine is finally prioritizing gender equality

What Congress can do to address the rural doctor shortage

How one medical school became remarkably diverse

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

focus

Sweden knocks USA out of World Cup in penalty kicks

With heat waves through August, officials warn of health risks

Feed a cold, starve a fever? Here’s what science says

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

NFL doctors' conflicts of interest could endanger players, report says

Readout LOUD podcast: possible new ALS drug, artificial wombs

leisure time

focus

focus

knowledge